Histidine supplement to boost immunity in colorectal cancer
Part of Cancer, Digestive system clinical trials.
This study tests whether taking a histidine supplement (an amino acid building block) alongside standard colorectal cancer treatment helps your immune system fight the cancer better. Researchers want to see if this simple addition can improve outcomes for people with stage II or higher colorectal cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18–80 years old
- Your body mass index (BMI) is 18.5 or higher
- You have stage II or higher colorectal cancer and need medical treatment
- You can swallow and take oral medication by mouth
- You are not currently in another study testing drugs, supplements, or devices
- You have no severe digestive problems like bleeding, vomiting, or blockages that would prevent you from taking this supplement
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether intravenous vitamin C (ascorbic acid) combined with an immune treatment (adebrelimab) can slow or shrink metastatic colorectal cancer that can’t be removed with surgery. It focuses on tumors that strongly show a specific marker called GLUT3, and aims to see if the combination works better than standard approaches.
This study looks at how the amino acid histidine in your body might affect how well immunotherapy (a treatment that helps your immune system fight cancer) works for colorectal cancer. If you join, the results could help doctors better predict which patients may benefit from this treatment.
This study tests how much protein people with colorectal or breast cancer need during treatment or recovery. It may help improve nutrition guidance and support for maintaining health during chemo or after surgery.
This trial tests whether taking a nutritional supplement before and after surgery can help patients with colorectal cancer recover better after their operation. It may improve nutrition and healing, but we need to check if you are eligible first.
This study looks at how diet and gut bacteria affect colon cancer risk in Black and Non-Hispanic White adults aged 45 to 75 who are at higher risk. You would donate mouth and stool samples and complete food recalls.
This study looks at how gut bacteria and immune activity differ in normal, pre-cancer, and cancer colon tissue. It may help researchers understand what changes in the body are linked to colon growth and how they could be targeted in the future.
Hear when a new Colorectal cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.